This achievement follows Bahrain’s landmark decision on 2 December 2023 to become the second country globally and the first ...
Accumulation of clots causes some of the most severe symptoms of sickle cell disease, including strokes, kidney failure, ...
A cutting-edge gene therapy has been approved for NHS use for some patients with severe sickle cell disease ... the Nobel Prize for chemistry in 2020. It works by editing the faulty gene in a ...
Vascarta's transdermal curcumin gel formulation ("VAS-101") experienced reduced pain and inflammation along with improved red blood cell stability and functionality. Based in part on these favorable ...
It is believed around 1,700 people could be eligible for the treatment, while the NHS estimates around 50 people a year will ...
Sickle cell disease is a group of inherited blood disorders that ... Emmanuelle Charpentier and Jennifer A. Doudna, the Nobel Prize in Chemistry in 2020. Exa-cel, also called Casgevy, involves taking ...
MANAMA, Feb. 16 (Xinhua) -- Bahrain has achieved a medical milestone by successfully treating a patient with sickle cell disease (SCD) using CRISPR-based gene-editing therapy, Casgevy, the Bahrain ...
Hydration is an important part of preventing and treating sickle cell crises, writes columnist Oluwatosin Adesoye, who shares ...
A cutting-edge gene therapy has been approved for NHS use for some patients with severe sickle ... for chemistry in 2020. It works by editing the faulty gene in a patient’s own stem cells.
But not if you suffer from sickle cell disease, which affects nearly 8 million people worldwide, most in sub-Saharan Africa. In the UK, approximately 17,500 people have sickle cell disease and 300 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results